02.06.2013 Views

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The structure and content of this discussion<br />

follows the revised Consolidated Standards<br />

<strong>for</strong> Reporting of Trials (CONSORT) statement<br />

<strong>for</strong> reporting randomised trials. 262<br />

The overall aim of the CESA project was to assess<br />

the relative cost-effectiveness of different anaesthetic<br />

agents in adult and paediatric day surgery.<br />

The rationale <strong>for</strong> this was a perceived need to<br />

provide the NHS with new and reliable in<strong>for</strong>mation<br />

about the relative value <strong>for</strong> money of<br />

alternative methods of anaesthesia. The CESA<br />

project is based on the premise that that there are<br />

no differences in the long-term clinical outcomes,<br />

such as death, respiratory and cardiac sequelae or<br />

long-term cognitive differences, associated with the<br />

use of different anaesthetic agents and techniques.<br />

The optimal choice of anaesthetic agent <strong>for</strong> daysurgery<br />

anaesthesia depends on the profile of<br />

short-term, transient effects, patient preferences<br />

and the costs of the alternatives.<br />

The CESA project comprised three interrelated<br />

studies to assess these short-term clinical, patient<br />

and cost outcomes. The first of these studies was a<br />

literature review of the clinical, patient outcome<br />

and economic literature to assess the evidence<br />

currently available. Secondly, a survey of current<br />

practice in anaesthesia <strong>for</strong> day surgery was undertaken.<br />

Both the literature review and the national<br />

survey were used to in<strong>for</strong>m the design of an RCT<br />

of alternative anaesthetic agents, which was the<br />

third component of the project (CESA RCT).<br />

This chapter summarises the findings of each of<br />

these components of the CESA project. Practical<br />

problems encountered in the implementation of<br />

the CESA RCT are presented, followed by a<br />

discussion of the internal and external validity<br />

of the CESA RCT. Finally, key conclusions are<br />

drawn <strong>for</strong> health policy, clinical practice and<br />

the need <strong>for</strong> future research.<br />

Findings of the study<br />

Literature review<br />

The literature review of clinical papers identified<br />

a large number of high-quality RCTs (grade I) of<br />

methods of anaesthesia and anaesthetic agents used<br />

in adult and paediatric day surgery. However, the<br />

© Queen’s Printer and Controller of HMSO 2002. All rights reserved.<br />

Chapter 7<br />

Discussion<br />

<strong>Health</strong> <strong>Technology</strong> Assessment 2002; Vol. 6: No. 30<br />

comparability of the studies was low, owing<br />

to a wide variation in the patient groups, anaesthetic<br />

agents and treatment protocols, surgical<br />

procedures and primary clinical outcomes used.<br />

PONV was the most commonly used measure,<br />

but varied in how and when it was measured.<br />

There<strong>for</strong>e, few firm conclusions could be drawn<br />

about the relative effectiveness of frequently used<br />

alternative agents. The review of patient-based<br />

outcomes identified mainly descriptive studies,<br />

with very few comparative evaluations. The review<br />

of the cost and economic literature yielded a<br />

small number of low-quality evaluations.<br />

The overall findings of the literature review<br />

were that:<br />

• the available evidence on short-term outcomes<br />

concentrated on predischarge PONV and<br />

discharge times<br />

• there was no clinical, patient-based outcome<br />

or economic evidence to indicate the optimal<br />

agent <strong>for</strong> anaesthesia in day surgery<br />

• there was no clinical, patient-based outcome<br />

or economic evidence to indicate the optimal<br />

method of induction (inhalational or<br />

intravenous) anaesthesia in day surgery<br />

• TIVA is not yet standard practice in anaesthesia<br />

<strong>for</strong> day surgery in paediatric patients<br />

• desflurane is not used in British practice and<br />

is not an appropriate comparator<br />

• the tools used to measure outcomes were<br />

varied and mostly unvalidated<br />

• patients may not consider PONV, mode of<br />

anaesthesia or cognitive function to be<br />

important outcomes.<br />

National survey of anaesthetic practice<br />

<strong>for</strong> paediatric and adult day surgery<br />

For adult day surgery, current practice is one of no<br />

premedication, a preference <strong>for</strong> induction with propofol<br />

and maintenance with isoflurane. One-tenth<br />

of respondents reported use of propofol <strong>for</strong> maintenance<br />

and one-fifth reported use of sevoflurane.<br />

A very small minority of respondents reported using<br />

desflurane. After induction, fresh gas flow rates are<br />

restricted to around 3 1/min, reflecting moderate<br />

but not ultra-low flow anaesthesia. Laryngeal masks<br />

are used in virtually all patients. Prophylactic antiemetics<br />

were used by approximately half of the<br />

81

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!